ArticleNature communications2019

Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy.

Jennifer L Caswell-Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.